Nandini Venkateswaran, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cataract | 8 | 2022 | 834 | 2.770 |
Why?
|
Cataract Extraction | 5 | 2024 | 481 | 1.990 |
Why?
|
Lens, Crystalline | 3 | 2021 | 388 | 1.830 |
Why?
|
Lenses, Intraocular | 4 | 2024 | 140 | 1.690 |
Why?
|
Phacoemulsification | 4 | 2022 | 149 | 1.550 |
Why?
|
Conjunctival Neoplasms | 3 | 2021 | 79 | 1.520 |
Why?
|
Keratitis | 2 | 2022 | 268 | 1.290 |
Why?
|
Endothelium, Corneal | 3 | 2022 | 199 | 1.050 |
Why?
|
Lens Capsule, Crystalline | 2 | 2022 | 43 | 0.970 |
Why?
|
Lens Implantation, Intraocular | 3 | 2024 | 192 | 0.920 |
Why?
|
Conjunctiva | 4 | 2022 | 494 | 0.920 |
Why?
|
Descemet Stripping Endothelial Keratoplasty | 2 | 2022 | 109 | 0.910 |
Why?
|
Iris | 3 | 2022 | 239 | 0.790 |
Why?
|
Asclepias | 1 | 2020 | 1 | 0.770 |
Why?
|
Dendritic Cell Sarcoma, Follicular | 1 | 2020 | 30 | 0.750 |
Why?
|
Corneal Perforation | 1 | 2020 | 32 | 0.740 |
Why?
|
Corneal Edema | 1 | 2020 | 52 | 0.730 |
Why?
|
Eye Neoplasms | 2 | 2019 | 313 | 0.710 |
Why?
|
Pemphigus | 1 | 2020 | 103 | 0.710 |
Why?
|
Ophthalmology | 2 | 2023 | 508 | 0.690 |
Why?
|
Paraneoplastic Syndromes | 1 | 2020 | 151 | 0.680 |
Why?
|
Eye Infections, Parasitic | 1 | 2018 | 24 | 0.660 |
Why?
|
Cysticercosis | 1 | 2018 | 34 | 0.650 |
Why?
|
Keratomileusis, Laser In Situ | 1 | 2019 | 88 | 0.650 |
Why?
|
Corneal Diseases | 3 | 2021 | 636 | 0.650 |
Why?
|
Lightning Injuries | 1 | 2018 | 2 | 0.640 |
Why?
|
Endophthalmitis | 1 | 2021 | 262 | 0.630 |
Why?
|
Eye Diseases | 2 | 2013 | 669 | 0.600 |
Why?
|
Ectopia Lentis | 1 | 2016 | 20 | 0.580 |
Why?
|
Vitrectomy | 1 | 2018 | 365 | 0.520 |
Why?
|
Optic Disk | 1 | 2019 | 400 | 0.520 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2018 | 640 | 0.500 |
Why?
|
Eye Injuries | 1 | 2018 | 245 | 0.490 |
Why?
|
Marfan Syndrome | 1 | 2016 | 240 | 0.490 |
Why?
|
Fluorouracil | 1 | 2018 | 1619 | 0.470 |
Why?
|
Aniridia | 1 | 2013 | 37 | 0.470 |
Why?
|
Keratoconjunctivitis | 1 | 2013 | 53 | 0.460 |
Why?
|
Surgery, Computer-Assisted | 2 | 2019 | 1018 | 0.460 |
Why?
|
Anterior Chamber | 1 | 2013 | 197 | 0.440 |
Why?
|
Visual Acuity | 3 | 2024 | 2530 | 0.440 |
Why?
|
Refractive Surgical Procedures | 1 | 2012 | 25 | 0.440 |
Why?
|
Gram-Positive Bacteria | 1 | 2013 | 184 | 0.430 |
Why?
|
Iris Diseases | 1 | 2012 | 40 | 0.430 |
Why?
|
Artificial Organs | 1 | 2013 | 204 | 0.390 |
Why?
|
Glaucoma Drainage Implants | 1 | 2012 | 116 | 0.390 |
Why?
|
Trabeculectomy | 1 | 2012 | 160 | 0.380 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2013 | 341 | 0.380 |
Why?
|
Eye Infections, Bacterial | 1 | 2013 | 235 | 0.370 |
Why?
|
Ophthalmic Solutions | 3 | 2021 | 317 | 0.330 |
Why?
|
Vision Disorders | 2 | 2013 | 1058 | 0.330 |
Why?
|
Microscopy, Acoustic | 2 | 2021 | 45 | 0.310 |
Why?
|
Cornea | 3 | 2021 | 1524 | 0.310 |
Why?
|
Retina | 1 | 2018 | 2616 | 0.300 |
Why?
|
Tomography, Optical Coherence | 4 | 2021 | 2657 | 0.290 |
Why?
|
Diagnostic Imaging | 1 | 2021 | 3507 | 0.290 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2019 | 4034 | 0.280 |
Why?
|
Funnel Chest | 1 | 2023 | 71 | 0.220 |
Why?
|
Amphotericin B | 1 | 2022 | 137 | 0.210 |
Why?
|
Internship and Residency | 1 | 2023 | 5788 | 0.210 |
Why?
|
Descemet Membrane | 1 | 2022 | 73 | 0.210 |
Why?
|
Keratoconus | 1 | 2023 | 121 | 0.210 |
Why?
|
Carnobacteriaceae | 1 | 2021 | 10 | 0.200 |
Why?
|
Pupil Disorders | 1 | 2021 | 33 | 0.190 |
Why?
|
Trigeminal Nerve Diseases | 1 | 2021 | 55 | 0.190 |
Why?
|
Polyesters | 1 | 2022 | 363 | 0.190 |
Why?
|
Sclera | 1 | 2022 | 200 | 0.190 |
Why?
|
Meibomian Glands | 1 | 2020 | 85 | 0.180 |
Why?
|
Complex Regional Pain Syndromes | 1 | 2021 | 124 | 0.180 |
Why?
|
Keratoplasty, Penetrating | 1 | 2021 | 155 | 0.180 |
Why?
|
Humans | 34 | 2024 | 744343 | 0.180 |
Why?
|
Corneal Topography | 1 | 2019 | 69 | 0.180 |
Why?
|
Platelet-Rich Plasma | 1 | 2022 | 177 | 0.170 |
Why?
|
Keratoacanthoma | 1 | 2019 | 33 | 0.170 |
Why?
|
Anterior Eye Segment | 1 | 2020 | 152 | 0.160 |
Why?
|
Microscopy, Confocal | 2 | 2021 | 1970 | 0.160 |
Why?
|
Ophthalmoscopy | 1 | 2018 | 176 | 0.160 |
Why?
|
Corneal Transplantation | 1 | 2022 | 386 | 0.150 |
Why?
|
Conjunctivitis, Allergic | 1 | 2018 | 130 | 0.150 |
Why?
|
Vancomycin | 1 | 2021 | 501 | 0.150 |
Why?
|
Fundus Oculi | 1 | 2018 | 473 | 0.150 |
Why?
|
Alkylating Agents | 1 | 2017 | 139 | 0.150 |
Why?
|
Postoperative Complications | 3 | 2021 | 15295 | 0.150 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2021 | 11725 | 0.140 |
Why?
|
Mitomycin | 1 | 2017 | 259 | 0.140 |
Why?
|
Uveitis | 1 | 2020 | 375 | 0.140 |
Why?
|
Conjunctival Diseases | 1 | 2017 | 122 | 0.140 |
Why?
|
Viscosity | 1 | 2016 | 328 | 0.140 |
Why?
|
Intraocular Pressure | 3 | 2021 | 1270 | 0.130 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2019 | 349 | 0.130 |
Why?
|
Comprehension | 1 | 2021 | 610 | 0.130 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13695 | 0.130 |
Why?
|
Tissue Scaffolds | 1 | 2022 | 956 | 0.130 |
Why?
|
Cyclophosphamide | 1 | 2020 | 2242 | 0.120 |
Why?
|
Perception | 1 | 2021 | 1198 | 0.120 |
Why?
|
Fluorescein Angiography | 1 | 2018 | 940 | 0.120 |
Why?
|
Aged | 9 | 2024 | 163280 | 0.110 |
Why?
|
Gonioscopy | 1 | 2012 | 157 | 0.110 |
Why?
|
Female | 12 | 2024 | 380194 | 0.100 |
Why?
|
Glaucoma | 1 | 2020 | 1159 | 0.090 |
Why?
|
Heart-Assist Devices | 1 | 2020 | 1194 | 0.090 |
Why?
|
Referral and Consultation | 2 | 2020 | 3528 | 0.090 |
Why?
|
Curriculum | 1 | 2023 | 3605 | 0.090 |
Why?
|
DNA, Bacterial | 1 | 2013 | 1465 | 0.080 |
Why?
|
Male | 10 | 2023 | 350118 | 0.080 |
Why?
|
Middle Aged | 6 | 2021 | 213383 | 0.070 |
Why?
|
Glaucoma, Open-Angle | 1 | 2012 | 706 | 0.070 |
Why?
|
Retrospective Studies | 5 | 2021 | 77449 | 0.070 |
Why?
|
Aged, 80 and over | 3 | 2019 | 57776 | 0.050 |
Why?
|
Adolescent | 4 | 2021 | 85781 | 0.050 |
Why?
|
Biological Dressings | 1 | 2021 | 30 | 0.050 |
Why?
|
Iran | 1 | 2023 | 708 | 0.050 |
Why?
|
Nerve Growth Factor | 1 | 2021 | 149 | 0.050 |
Why?
|
Muscle Weakness | 1 | 2023 | 413 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2018 | 9239 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39050 | 0.050 |
Why?
|
Tissue Adhesions | 1 | 2021 | 235 | 0.040 |
Why?
|
Tears | 1 | 2020 | 256 | 0.040 |
Why?
|
Remission, Spontaneous | 1 | 2019 | 382 | 0.040 |
Why?
|
Cryotherapy | 1 | 2019 | 155 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2013 | 12959 | 0.040 |
Why?
|
Anesthesia, Local | 1 | 2020 | 275 | 0.040 |
Why?
|
Young Adult | 2 | 2021 | 56430 | 0.040 |
Why?
|
Reading | 1 | 2021 | 558 | 0.040 |
Why?
|
Atrophy | 1 | 2021 | 1583 | 0.030 |
Why?
|
Child, Preschool | 2 | 2020 | 41006 | 0.030 |
Why?
|
Cosmetic Techniques | 1 | 2017 | 135 | 0.030 |
Why?
|
Dry Eye Syndromes | 1 | 2020 | 386 | 0.030 |
Why?
|
United States | 1 | 2023 | 69872 | 0.030 |
Why?
|
Benchmarking | 1 | 2021 | 1042 | 0.030 |
Why?
|
Motivation | 1 | 2024 | 1971 | 0.030 |
Why?
|
Regeneration | 1 | 2022 | 1485 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2021 | 6622 | 0.030 |
Why?
|
Adult | 2 | 2023 | 214055 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2022 | 3479 | 0.020 |
Why?
|
Pilot Projects | 1 | 2019 | 8324 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2019 | 4042 | 0.020 |
Why?
|
Prospective Studies | 2 | 2020 | 53288 | 0.020 |
Why?
|
Body Mass Index | 1 | 2020 | 12720 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 63114 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8388 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 25043 | 0.010 |
Why?
|
Mutation | 1 | 2023 | 29786 | 0.010 |
Why?
|
Child | 1 | 2020 | 77709 | 0.010 |
Why?
|